Publisher： Bentham Science Publishers
E-ISSN： 2211-7393|1|3|204-212
ISSN： 2211-7385
Source： Pharmaceutical Nanotechnology, Vol.1, Iss.3, 2013-07, pp. : 204-212
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
The present work explores the preparation and characterization of chitosan/lecithin nanoparticles loaded with arteether (ART) and arteether entrapped in cyclodextrins (ART-&bgr; CD) to boost its anti-malarial activity. Arteether, an antimalarial drug was chosen by the Steering Committee of the Scientific Working Group on Malaria Chemotherapy of the WHO (CHEMAL) for treatment of cerebral malaria. Unfortunately, ART is water-insoluble drug (17 μg/ml at room temp.) and its therapeutic efficacy is greatly hampered due to poor bioavailability (∼40%, degradation in stomach acids). Moreover, Arteether have short plasma half-life which requires frequent administration. Formation of nanoparticles of ART can be a suitable solution to improve their Biopharmaceutical properties. The nanoparticles prepared using modified solvent evaporation method depicted a particle size in the range of 299-354 nm for arteether and 157-212 nm for ART-&bgr; CD loaded nanoparticles. 100 mg loaded ART and ART-&bgr; CD formulations showed maximum drug entrapment efficiency. Prepared nanoparticles reflected spherical shape inTEM images. Disappearance of decomposition endotherm in DSC scans of nanoparticles revealed the increased physical stability. FT-IR spectra showed small changes in major peaks of drug negating any chemical change in the drug when entrapped in the nanoparticle formulation. In vitro drug release studies suggested the controlled release as well as improved pattern. Enhanced antimalarial activity was observed in ART and ART-&bgr; CD containing nanoparticles.
Related content
Access to resources
Recommend
